- Thread Author
- #1
- Joined
- Sep 29, 2023
- Messages
- 868
- Reaction score
- 132
- Trophy Points
- 4
- Location
- Morganton, NC
- D Bucks
- 💵2.737100
- Referral Credit
- 0
![Global Connector Emblem NFT [Common]](/data/dbtechShop/itemIcons/0/3.jpg?1702360984)
(The Guardian) Trump announces deals with another nine drugmakers to lower prices
A short while ago, Donald Trump announced deals with nine major pharmaceutical companies that will lower the prices of some medicines.
It brings the total number of drugmakers the administration has reached deals with to 14, with Amgen, Boehringer Ingelheim, Bristol Myers Squibb, Roche’s Genentech unit, Gilead, GSK, Merck, Novartis and Sanofi all participating in today’s announcement.
“This is the biggest thing ever to happen on drug pricing and on healthcare. This will have a tremendous impact on health care itself,” Trump said in the Roosevelt Room at the White House, flanked by the pharmaceutical companies’ chief executives.
“They’re going to pay our country the lowest price paid anywhere in the world, and they will list their most popular drugs on TrumpRX.gov,” he added.
Trump previously announced agreements with Pfizer, AstraZeneca, EMD Serono, Eli Lilly and Novo Nordisk after he sent letters out in July to all 17 companies, urging them to offer so-called most-favored-nation prices to Medicaid and ensure new medicines launch at prices no higher than those in other wealthy countries. In return, the companies that reached deals secured three-year exemptions from any tariffs Trump might slap on imported pharmaceuticals in the future.
AbbVie, Johnson & Johnson and Regeneron are the last major drugmakers that have yet to announce deals with the administration. Trump said he would be meeting with them in the coming weeks in an effort to get them to sign on to lowering their costs.
A short while ago, Donald Trump announced deals with nine major pharmaceutical companies that will lower the prices of some medicines.
It brings the total number of drugmakers the administration has reached deals with to 14, with Amgen, Boehringer Ingelheim, Bristol Myers Squibb, Roche’s Genentech unit, Gilead, GSK, Merck, Novartis and Sanofi all participating in today’s announcement.
“This is the biggest thing ever to happen on drug pricing and on healthcare. This will have a tremendous impact on health care itself,” Trump said in the Roosevelt Room at the White House, flanked by the pharmaceutical companies’ chief executives.
“They’re going to pay our country the lowest price paid anywhere in the world, and they will list their most popular drugs on TrumpRX.gov,” he added.
Trump previously announced agreements with Pfizer, AstraZeneca, EMD Serono, Eli Lilly and Novo Nordisk after he sent letters out in July to all 17 companies, urging them to offer so-called most-favored-nation prices to Medicaid and ensure new medicines launch at prices no higher than those in other wealthy countries. In return, the companies that reached deals secured three-year exemptions from any tariffs Trump might slap on imported pharmaceuticals in the future.
AbbVie, Johnson & Johnson and Regeneron are the last major drugmakers that have yet to announce deals with the administration. Trump said he would be meeting with them in the coming weeks in an effort to get them to sign on to lowering their costs.
